BioPharmSignal logoBioPharmSignal

Biotech News

MIMEDX to Participate in Upcoming Investor Conferences

MiMedx (MDXG)MiMedxConference / presentation

MARIETTA, Ga., Sept. 08, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences: Cantor Global Healthcare Conference | New York, NY Wednesday, September 9,

Related news

MDXGMiMedx2026-05-21 12:45 EST

MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference

CHRSCoherus BioSciences, Inc.2026-08-31 13:30 EST

Coherus to Participate in Upcoming Investor Conferences

CHRSCoherus BioSciences, Inc.2026-02-23 14:30 EST

Coherus Oncology to Participate in Upcoming Investor Conferences

PHARPharming Group2026-09-09 06:00 EST

Pharming Group to participate in September investor conferences

IBIOIbio Inc2026-09-01 20:30 EST

iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference

PHARPharming Group2026-06-02 06:00 EST

Pharming Group to participate in Fireside Chat at 2026 Jefferies Global Healthcare Conference in New York

IBIOIbio Inc2025-11-24 21:15 EST

iBio to Participate in the 8th Annual Evercore Healthcare Conference

MDXGMiMedx2026-04-02 13:15 EST

MIMEDX to Sponsor Leading Advanced Wound Care Conferences

STTKShattuck Labs2025-04-02 21:00 EST

Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference

ENTXEntera Bio2026-07-31 20:30 EST

Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference

View all latest news

MiMedx

Placental Tissue Products MIMEDX develops and commercializes placental-tissue products for wound care, burns and surgery. Its processing and product portfolio are designed to provide extracellular-matrix and biologic materials that support healing and tissue repair. Wound-Care Portfolio The company has more than a decade of experience...

Recent company news

MDXGMiMedx2026-09-08 12:00 EST

MIMEDX to Participate in Upcoming Investor Conferences

MDXGMiMedx2026-07-29 20:07 EST

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

MDXGMiMedx2026-07-29 20:01 EST

MIMEDX to Acquire Sanara MedTech

MDXGMiMedx2026-07-20 12:00 EST

MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29

MDXGMiMedx2026-05-21 12:45 EST

MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference

Stock data

Close
4.69 USD
Market cap
531.74M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States